as 05-30-2025 4:00pm EST
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
Founded: | N/A | Country: | Canada |
Employees: | N/A | City: | QUEBEC |
Market Cap: | 1.7B | IPO Year: | N/A |
Target Price: | $7.20 | AVG Volume (30 days): | 1.5M |
Analyst Decision: | Hold | Number of Analysts: | 5 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -0.11 | EPS Growth: | N/A |
52 Week Low/High: | $3.96 - $9.85 | Next Earning Date: | 04-30-2025 |
Revenue: | $9,731,000,000 | Revenue Growth: | 8.53% |
Revenue Growth (this year): | 3.71% | Revenue Growth (next year): | 5.03% |
BHC Breaking Stock News: Dive into BHC Ticker-Specific Updates for Smart Investing
Zacks
a day ago
Simply Wall St.
3 days ago
StockStory
4 days ago
StockStory
10 days ago
MT Newswires
10 days ago
ACCESS Newswire
17 days ago
StockStory
18 days ago
Zacks
19 days ago
The information presented on this page, "BHC Bausch Health Companies Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.